Right ventricular outflow tract thrombus in a case of Behcet's disease

Necla Ozer1, Orçun Ciftçi, Metin Demirci

  • 1Cardiology Department, Hacettepe University, Faculty of Medicine, Ankara, Turkey. neclaozer@hotmail-com

Insights

Behcet's disease, a vasculitic syndrome, rarely involves the heart. This case study details a young woman who developed a right ventricular thrombus during medical treatment for Behcet's disease.

Area of Science:

  • Cardiology
  • Rheumatology
  • Systemic Vasculitis

Background:

  • Behcet's disease is a chronic systemic vasculitic syndrome characterized by oral/genital ulcers and uveitis.
  • Vascular complications, primarily thrombosis, affect up to one-third of patients.
  • Cardiac involvement in Behcet's disease is exceptionally rare.

Observation:

  • A young female patient with Behcet's disease was undergoing medical treatment.
  • The patient developed a thrombus in her right ventricle.

Findings:

  • The case highlights an unusual cardiac manifestation of Behcet's disease.
  • Right ventricular thrombus formation occurred during medical management.

Implications:

  • This case underscores the importance of considering cardiac complications in Behcet's disease, even when rare.
  • Further investigation into cardiac involvement in Behcet's disease may be warranted.
  • Understanding rare cardiac manifestations can refine patient monitoring and treatment strategies.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...